Thursday, October 15, 2020
Start time: 3pm (Jerusalem), 2pm (Paris), 8am (NYC), 8pm (Hong Kong)
Click to register for this event (October 15th)
Scientific program
15:00-15:05 - Opening Remarks
Prof. Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel
15:05-16:00 - Gamma -Delta based immunotherapy for hematological malignancies
Prof. Dr. Jürgen Kuball, Director of the Bone Marrow Transplantation Program at the University Medical Center in Utrecht, The Netherlands
16:00-16:30 - Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Dr Michal J Besser, Ella Lemelbaum Institute for Immuno Oncology Sheba Medical Center, Tel Aviv, Israel
16:30-17:00 - Relapse of AML post Allo-an unmet need
Prof Tzila Zuckerman, Director of the Department of Hematology and Bone Marrow Transplantation at Rambam Health Care Campus, Haifa, Israel
17:10-17:40 - Role of MRD in Allo for AML
Prof Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel
17:40-18:00 - CAR-T cells for DLBCL in patients over vs under 70y
Prof Ron Ram, Director, The Bone Marrow Transplantation Unit; The Division of Hematology,Tel Aviv Sourasky Medical Center,Tel Aviv ,Israel
17:50-18:10 - Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation – The Diagnostic Yield of Stool Cultures. A Retrospective Cohort Study
Dr Tamar Berger, Rabin Medical Center, Petach –Tikva, Israel
18:10-18:30 - Transplantation in Fanconi Anemia
Dr Even-Or Ehud, Pediatric Bone Marrow Transplantation, Hadassah Medical Center, Jerusalem, Israel
18:30-19:00 - Summary, Q&A
Prof Nagler, Prof Zuckerman and Faculty
This event is supported by an unrestricted grant from Astellas
